首页> 外文期刊>Liver international : >Endogenous alpha-calcitonin gene-related peptide mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin A.
【24h】

Endogenous alpha-calcitonin gene-related peptide mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin A.

机译:内源性α-降钙素基因相关肽可减轻反复服用伴刀豆球蛋白A诱导的慢性肝炎的肝纤维化。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Alpha-calcitonin gene-related peptide (alphaCGRP) is a 37-amino acid pleiotropic peptide that we previously showed to exert a hepatoprotective effect during concanavalin A (Con A)-induced acute hepatitis. In the present study, we used alphaCGRP(-/-) mice to further investigate the antifibrogenic and hepatoprotective effects of endogenous alphaCGRP in Con A-induced chronic hepatitis. METHODS: Chronic hepatitis was induced in alphaCGRP(-/-) and wild-type mice by repeated administration of Con A. Serum transaminases were measured to assess hepatic injury. The severity of fibrosis and the activation of hepatic stellate cells (HSCs) were analysed by Masson trichrome staining and immunohistochemical staining of alpha-smooth muscle actin (alpha-SMA) respectively. Altered expression of fibrosis- and inflammation-related genes was evaluated using a quantitative real-time polymerase chain reaction. Activation and proliferation of HSCs were analysed using both primary cultured HSCs from the mice and the LI90 HSC cell line. RESULTS: alphaCGRP(-/-) mice showed more severe liver fibrosis than wild-type mice in a Con A-induced chronic hepatitis model. In histological and gene expression analyses, alphaCGRP(-/-) mice showed greater inflammatory and fibrotic changes, greater HSC activation and a higher incidence of apoptosis among nonparenchymal cells than wild-type mice. CONCLUSIONS: Endogenous alphaCGRP mitigates liver fibrosis in chronic hepatitis induced by repeated administration of Con A. alphaCGRP could be a useful therapeutic target for the treatment of chronic hepatitis.
机译:背景:降钙素基因相关肽(alphaCGRP)是一种37个氨基酸的多效肽,我们先前证明在伴刀豆球蛋白A(Con A)诱导的急性肝炎中具有保肝作用。在本研究中,我们使用alphaCGRP(-/-)小鼠进一步研究了内源性αCGRP在Con A诱发的慢性肝炎中的抗纤维化和肝保护作用。方法:反复施用Con A可诱导αCGRP(-/-)和野生型小鼠诱发慢性肝炎。测量血清转氨酶以评估肝损伤。纤维化的严重程度和肝星状细胞(HSCs)的激活分别通过Masson三色染色和α-平滑肌肌动蛋白(alpha-SMA)的免疫组织化学染色进行分析。使用定量实时聚合酶链反应评估纤维化和炎症相关基因的表达变化。使用来自小鼠的原代培养的HSC和LI90 HSC细胞系来分析HSC的活化和增殖。结果:在Con A诱发的慢性肝炎模型中,alphaCGRP(-/-)小鼠比野生型小鼠表现出更严重的肝纤维化。在组织学和基因表达分析中,与野生型小鼠相比,alphaCGRP(-/-)小鼠在非实质细胞中表现出更大的炎症和纤维化变化,更大的HSC活化以及更高的凋亡发生率。结论:内源性αCGRP减轻了反复服用Con A引起的慢性肝炎的肝纤维化。αCGRP可能是治疗慢性肝炎的有用治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号